These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2950422)

  • 1. [Anti-LAV/HTLV III antibodies in patients under hemodialysis receiving blood transfusion protocols. A retrospective study of 2 transplant centers].
    Ferec C; Deroff P; Bourbigot B; Herve JP; Le Guy P; Bignon JD; Boudard D; Soulillou JP
    Presse Med; 1986 Sep; 15(29):1378. PubMed ID: 2950422
    [No Abstract]   [Full Text] [Related]  

  • 2. HTLV-III/LAV infection in hemodialysis patients.
    Peterman TA; Lang GR; Mikos NJ; Solomon SL; Schable CA; Feorino PM; Britz JA; Allen JR
    JAMA; 1986 May; 255(17):2324-6. PubMed ID: 3007792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-III antibodies in hemodialysis patients--a consequence of blood transfusions?
    Schaefer K; Asmus G; Hüfler M; von Herrath D
    Klin Wochenschr; 1986 Jul; 64(13):621-2. PubMed ID: 3018352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of human T-lymphotropic virus III serology in a renal transplant population.
    Kerman RH; Flechner SM; Van Buren CT; Lorber MI; Dawson G; Falk L; Gutierrez R; Hollinger JB; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2172-5. PubMed ID: 3547918
    [No Abstract]   [Full Text] [Related]  

  • 5. [Epidemiology of infection by LAV/HTLV-III virus in hemophiliacs multitransfused in France. Results of a survey conducted by 28 hemophilia centers].
    Sultan Y
    Nouv Rev Fr Hematol (1978); 1986; 28(5):327-9. PubMed ID: 3643509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transfusion-associated LAV/HTLV-III infections in Switzerland. Report of 2 cases].
    Flepp M; Täuber MG; Lüthy R; Frauchiger B; Barandun J; Schütze M; Joller H; Frey-Wettstein M; Vetter W; Siegenthaler W
    Schweiz Med Wochenschr; 1986 Apr; 116(14):426-8. PubMed ID: 3008323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-LAV/HTLV III antibodies in wives of seropositive hemophilic patients].
    Bardin JM; Maisonneuve P; Nguyen M; Pinon F; Sultan Y
    Presse Med; 1986 Oct; 15(33):1686-7. PubMed ID: 2947123
    [No Abstract]   [Full Text] [Related]  

  • 8. [Retrospective serological analysis of HTLV-III/LAV antibody and immunity in hemophiliac patients in Shizuoka Prefecture].
    Mimaya J; Tonouchi T; Toyoda Y; Sugiyama T; Sonoda A; Fukuda F; Hattori T; Takatsuki K
    Rinsho Ketsueki; 1986 Jun; 27(6):866-71. PubMed ID: 3463806
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevalence of antibodies against LAV/HTLV-III in patients with terminal renal insufficiency treated with hemodialysis and following renal transplantation].
    Fassbinder W; Kühnl P; Neumayer HH; Offermann G; Seidl S; Schoeppe W
    Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1087-90. PubMed ID: 3015545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of renal transplant recipients.
    Feduska NJ; Perkins HA; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Garovoy M; Salvatierra O
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2161-6. PubMed ID: 3547917
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-HTLV-III antibodies in dialyzed or transplanted patients in Spain.
    Teixidó J; Argelagués E; Caralps A; Romero R; Oppenheimer F; Ricart MJ; Martorell J; Griñó JM; Solá R
    Nephron; 1987; 46(3):325-6. PubMed ID: 3306418
    [No Abstract]   [Full Text] [Related]  

  • 12. HTLV-III antibodies in patients with kidney transplants or on haemodialysis.
    Neumayer HH; Wagner K; Kresse S
    Lancet; 1986 Mar; 1(8479):497. PubMed ID: 2869226
    [No Abstract]   [Full Text] [Related]  

  • 13. [LAV/HTLV-III antibodies in blood and blood products].
    Gürtler L; Eberle J; Deinhardt F
    Dtsch Med Wochenschr; 1985 Oct; 110(43):1639-40. PubMed ID: 2994977
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems related to the risk of AIDS].
    Vallauri P
    Minerva Urol Nefrol; 1987; 39(2):169-71. PubMed ID: 3650954
    [No Abstract]   [Full Text] [Related]  

  • 15. [Guidelines for the management of patients infected by the human immunodeficiency virus].
    Ponce de León S; Ruiz-Palacios GM
    Rev Invest Clin; 1988; 40(1):47-63. PubMed ID: 3165542
    [No Abstract]   [Full Text] [Related]  

  • 16. Acquired immune deficiency syndrome (AIDS) HTLV III/LAV; the causal agent and modes of transmission.
    Smithies A
    Health Bull (Edinb); 1986 Jul; 44(4):234-8. PubMed ID: 3017891
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transmission of AIDS in Japan via blood component transfusion].
    Miyamoto T
    Rinsho Ketsueki; 1986 Jul; 27(7):1258-60. PubMed ID: 3640833
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection of neonates from transfusion-associated AIDS by the use of CMV-seronegative blood before availability of specific serologic tests for HTLV-III (HIV).
    Brady MT; Ng A
    Am J Perinatol; 1987 Oct; 4(4):305-7. PubMed ID: 2820434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
    Allain JP
    N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for antibodies to HTLV-III/LAV in our population. A word of caution.
    Zafar MN
    J Pak Med Assoc; 1987 Apr; 37(4):84-5. PubMed ID: 3108550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.